RAMESH KUMAR, PH.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Ocugen, Inc.

Filing Date Source Excerpt
2019-11-08 Dr. Kumar obtained an undergraduate and Master’s degree in Microbiology from Panjab University and received his Ph.D. in Molecular Biology from the University of Illinois, Chicago.
2020-10-30 Dr. Kumar obtained an undergraduate and Master’s degree in Microbiology from Panjab University and received his Ph.D. in Molecular Biology from the University of Illinois, Chicago.
2021-02-22 Ramesh Kumar, Ph.D.
2021-04-28 Dr. Kumar obtained an undergraduate and Master’s degree in Microbiology from Panjab University and received his Ph.D. in Molecular Biology from the University of Illinois, Chicago.
2022-04-28 Dr. Kumar obtained Bachelor's and Master's degrees in Microbiology and a Ph.D. in Molecular Biology from the University of Illinois, Chicago.
2023-04-20 Dr. Kumar obtained bachelor’s and master’s degrees in microbiology from Panjab University and received his Ph.D. in Molecular Biology from the University of Illinois, Chicago and trained at the National Cancer Institute.

Traws Pharma, Inc.

Filing Date Source Excerpt
2014-04-29 Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute.
2015-04-29 Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute.
2016-04-13 Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute.
2017-04-12 Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute.
2018-02-28 Ramesh Kumar, Ph.D.(7) 292,209 1.6% Includes (i) 37,510 shares of common stock held by the Ramesh Kumar 2012 Trust and (ii) 189,982 shares of common stock subject to outstanding warrants and options that are exercisable within 60 days of February 16, 2018.
2018-05-17 Ramesh Kumar, Ph.D. is listed as President and Chief Executive Officer and a director but no software-related skills or technical background are mentioned.
2018-06-08 Dr. Kumar received his Ph.D. in Molecular Biology from the University of Illinois, Chicago, and trained at the National Cancer Institute.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22